文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

促炎细胞因子在脓毒症中作用的研究进展

[Research advance on the role of pro-inflammatory cytokines in sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论综述指出IFN-β、IL-1β早期低剂量治疗可能通过恢复免疫细胞功能减轻脓毒症,但二者也与严重炎症反应及病死率升高相关。

脓毒症是感染引起的病理生理异常,是全球感染患者死亡和残疾的重要原因。细胞因子是细胞分泌的小分子活性蛋白,参与脓毒症免疫与炎症调控;多项以细胞因子为靶点治疗脓毒症的研究取得有益效果,细胞因子水平被认为与脓毒症发生、严重程度相关,是可靠的生物标志物。本综述聚焦促炎细胞因子干扰素-β(IFN-β)及白细胞介素(IL-1β、IL-3、IL-6、IL-7):IFN-β与IL-1β在脓毒症治疗中具有双面性,早期低剂量治疗可通过恢复免疫细胞功能减轻脓毒症并发挥保护作用,但也与脓毒症严重炎症反应相关、可加重患者病死率;IL-3与IL-6更侧重于增强炎症因子、起损伤作用;IL-7主要参与免疫调节,促进淋巴细胞活化并保护脓毒症。

要点

  • IFN-β与IL-1β在脓毒症治疗中具有双面性:早期低剂量治疗可通过恢复免疫细胞功能减轻脓毒症、发挥保护作用。
  • IFN-β与IL-1β也与脓毒症严重炎症反应相关,可加重脓毒症患者病死率。
  • IL-3与IL-6更侧重于增强炎症因子,在脓毒症中起损伤作用。
  • IL-7主要参与免疫调节,促进淋巴细胞活化并保护脓毒症。
  • 细胞因子水平被认为与脓毒症发生、严重程度相关,是可靠的脓毒症生物标志物。

研究设计与关键结果

  • 综述聚焦促炎细胞因子IFN-β及IL-1β、IL-3、IL-6、IL-7在脓毒症中的作用。
  • 多项以细胞因子为靶点治疗脓毒症的研究取得有益效果。
  • IFN-β与IL-1β早期低剂量治疗可通过恢复免疫细胞功能减轻脓毒症并发挥保护作用,但也与脓毒症严重炎症反应相关、可加重患者病死率。
  • IL-3与IL-6更侧重于增强炎症因子,起损伤作用;IL-7主要参与免疫调节,促进淋巴细胞活化并保护脓毒症。

证据类型、等级与局限

  • 证据类型:综述。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Sepsis, a series of pathophysiological abnormalities caused by infection, is also one of the most important factors of death and disability in infected patients all over the world, so it has always been the focus of the medical community. Cytokines are small molecule proteins secreted by cells with biological activity, involved in the immune and inflammatory regulation of sepsis. Many studies using cytokine targeting to treat sepsis have achieved beneficial effects, and the level of cytokines is also believed to be related to the development, severity of sepsis, so they are reliable biomarkers of sepsis. Among them, pro-inflammatory cytokines such as interferon-β (IFN-β) and interleukins (IL-1β, IL-3, IL-6, and IL-7) are the focus of the discussion in this review. IFN-β and IL-1β are double-sided in the treatment of sepsis, namely early low-dose treatment can reduce sepsis by restoring the function of immune cells and play a protective effect, but they are also related to severe inflammatory response of sepsis and can aggravate the mortality of sepsis patients. IL-3 and IL-6 focus more on enhancing inflammatory factors and play a damage role. IL-7 mainly participates in immune regulation, promoting lymphocyte activation and protecting sepsis.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen Y, Dong P, Zhang X, et al. [Research advance on the role of pro-inflammatory cytokines in sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916385. doi:10.3760/cma.j.cn121430-20220919-00846

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。